What: “Triple negative” breast cancer grows faster and is harder to treat than other types of breast cancers and makes up about 10-15% of cases. A study from Cedars-Sinai Cancer found these patients fell into three distinct groups: one group responded to immunotherapy, one did not, and most interestingly, one group responded only if there was radiation therapy plus immunotherapy.
Why it matters: This could give women with triple negative breast cancer more treatment options and save others from living with the side effects of tough cancer treatments that won’t work.
Source: Cedars-Sinai